Ad is loading...
FRLAX
Price
$19.90
Change
+$0.13 (+0.66%)
Updated
Nov 22 closing price
VGSNX
Price
$21.12
Change
+$0.18 (+0.86%)
Updated
Nov 22 closing price
Ad is loading...

FRLAX vs VGSNX

Header iconFRLAX vs VGSNX Comparison
Open Charts FRLAX vs VGSNXBanner chart's image
Franklin Real Estate Securities Adv
Price$19.90
Change+$0.13 (+0.66%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.12
Change+$0.18 (+0.86%)
VolumeN/A
CapitalizationN/A
FRLAX vs VGSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRLAX vs. VGSNX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRLAX is a Buy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 68.9B vs. FRLAX (285M). VGSNX pays higher dividends than FRLAX: VGSNX (4.01) vs FRLAX (2.19). FRLAX was incepted earlier than VGSNX: FRLAX (28 years) vs VGSNX (21 years). FRLAX is a more actively managed with annual turnover of: 10.69 vs. VGSNX (9.00). FRLAX has a lower initial minimum investment than VGSNX: FRLAX (100000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 25.16 vs. FRLAX (18.20). VGSNX return over 5 years is better than : 25.99 vs. FRLAX (-8.79).
FRLAXVGSNXFRLAX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years21 years-
Gain YTD9.91411.32888%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets285M68.9B0%
Annual Yield % from dividends2.194.0155%
Returns for 1 year18.2025.1672%
Returns for 3 years-11.65-1.26928%
Returns for 5 years-8.7925.99-34%
Returns for 10 years10.6468.9215%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCPH3.460.10
+2.98%
scPharmaceuticals
NDSN256.584.02
+1.59%
Nordson Corp
XENE39.800.46
+1.17%
Xenon Pharmaceuticals
RLAY4.64-0.02
-0.43%
Relay Therapeutics
AEI1.10-0.05
-4.35%
Alset